Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Patient-Derived Glioma Organoids: Preserving Tumor Microenvi
2026-04-30
This study introduces a novel glioma organoid model (GlioME) that retains the native tumor microenvironment, including immune components, enabling more physiologically relevant drug screening and therapeutic evaluation. By integrating genetic, epigenetic, and cellular analyses, the research establishes GlioME as a promising platform for personalized oncology studies.
-
Azilsartan Medoxomil Monopotassium: Potent AT1 Antagonist fo
2026-04-30
Azilsartan medoxomil monopotassium (TAK 491) is a highly selective angiotensin II type 1 receptor antagonist used in essential hypertension treatment research. It offers robust, sustained blood pressure lowering and is validated by systematic meta-analysis for efficacy and safety, including in populations with diabetes.
-
Carboxylesterase-Mediated Amplex Red Conversion: Impacts on
2026-04-29
This study reveals that carboxylesterases can convert Amplex Red to resorufin independently of hydrogen peroxide or horseradish peroxidase, leading to significant artifacts in mitochondrial H2O2 release assays. The findings prompt a re-evaluation of Amplex Red-based reactive oxygen species measurements and provide strategies for minimizing assay interference.
-
AO/PI Double Staining Kit: Practical Guide for Cell Viabilit
2026-04-29
The AO/PI Double Staining Kit enables the rapid and simultaneous discrimination of viable, apoptotic, and necrotic cells in a single assay, addressing essential needs in cell biology research. It is especially suited for workflows requiring clear, fluorescence-based cell viability and apoptosis detection, but should not be applied in settings where non-fluorescent or fixed-tissue analyses are required.
-
Spiroplasma eriocheiris Entry via Clathrin-Mediated Endocyto
2026-04-28
This study establishes that Spiroplasma eriocheiris invades Drosophila S2 cells primarily through clathrin-mediated endocytosis and macropinocytosis, processes that can be dissected using dynamin GTPase inhibitors. The findings clarify pathogen entry routes in invertebrate models, providing a robust experimental foundation for endocytosis research and applications in host-pathogen studies.
-
N3-kethoxal (SKU A8793): Reliable Probing for RNA & DNA Stru
2026-04-28
This article explores how N3-kethoxal (SKU A8793) elevates reproducibility and data quality in RNA secondary structure probing, genomic DNA mapping, and RNA–protein interaction identification. Scenario-driven Q&A blocks address lab realities, vendor reliability, and optimization, demonstrating the evidence-based advantages and workflow fit of this azide-functionalized nucleic acid probe.
-
CDK4/6 and BET Inhibitors Synergize in Pancreatic Cancer EMT
2026-04-27
Gu et al. (2025) reveal that dual inhibition of CDK4/6 and BET proteins produces a synergistic effect on suppressing pancreatic tumor growth and reversing EMT, primarily through modulation of the GSK3β-mediated Wnt/β-catenin and TGF-β/Smad pathways. These findings highlight the importance of combinatorial therapeutic strategies in overcoming the limitations of single-agent treatments in pancreatic ductal adenocarcinoma (PDAC) research.
-
Technical Use of Hoechst 33342/PI Double Staining Kit (K2237
2026-04-27
The Hoechst 33342/PI Double Staining Kit provides researchers with a standardized method for distinguishing apoptotic, necrotic, and viable cells in basic research. It is not intended for diagnostic or clinical use, but offers rapid, reliable fluorescent apoptosis and necrosis assessment in microscopy-based workflows.
-
Oligo (dT) 25 Beads: Actionable Guide for Eukaryotic mRNA Is
2026-04-26
Oligo (dT) 25 Beads are designed for efficient isolation of eukaryotic mRNA by targeting polyA tails, streamlining workflows for applications like RT-PCR and next-generation sequencing. This product is best suited for researchers handling total RNA from animal or plant tissues who require high-purity mRNA, but is not intended for prokaryotic RNA or workflows lacking polyadenylated transcripts.
-
Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye for Protein
2026-04-25
Sulfo-Cy3 NHS Ester offers highly water-soluble, low-quenching fluorescent labeling for proteins, enabling sensitive quantitation and robust workflows even with difficult targets. Its optimized chemistry supports advanced cell biology and vascular remodeling assays, with direct application to cutting-edge research on capillary dynamics.
-
UBC9-Regulated PINK1 SUMOylation Mitigates Oxidative Stress
2026-04-24
This study demonstrates that UBC9, a SUMO-conjugating enzyme, enhances mitophagy and attenuates oxidative stress in Parkinson’s disease (PD) models by promoting SUMOylation of PINK1. The findings provide mechanistic insight into neuroprotection via UBC9-mediated stabilization of PINK1, suggesting new avenues for PD intervention.
-
Moxifloxacin (SKU B1218): Assay Reliability in Cell Studies
2026-04-24
This article explores the practical solutions offered by Moxifloxacin (SKU B1218) for cell viability, proliferation, and cytotoxicity assays. Focusing on real laboratory scenarios and supported by quantitative data, it demonstrates how APExBIO’s Moxifloxacin ensures reproducibility, sensitivity, and workflow safety for biomedical researchers.
-
Bazedoxifene: Advanced SERM Strategies for Osteoporosis Rese
2026-04-23
Discover the molecular pharmacology of Bazedoxifene, a third-generation selective estrogen receptor modulator, and learn how its unique tissue-selective actions guide advanced osteoporosis treatment research. This article provides in-depth, evidence-based insights not found in standard SERM resources.
-
MHY1485: mTOR Activator for Autophagy and Ovarian Research
2026-04-23
MHY1485 offers unique control over the mTOR signaling pathway, enabling researchers to dissect autophagy dynamics and ovarian follicle development with precision. This guide details validated workflows, key troubleshooting steps, and strategic insights to maximize experimental impact with APExBIO's MHY1485.
-
USP7 Regulates Macrophage Polarization via PKM2 in Acute Pan
2026-04-22
This study elucidates how ubiquitin-specific protease 7 (USP7) drives pro-inflammatory macrophage polarization in severe acute pancreatitis (SAP) by modulating pyruvate kinase M2 (PKM2)-dependent metabolic reprogramming. The findings highlight a novel regulatory axis with implications for targeting immunometabolic pathways in inflammatory diseases.